Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Polycystic Ovary Syndrome
NCT02086526Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in Insulin Sensitivity (SI) at 3 months. Started Mar 2014; status: completed.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02086526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086526.